Status:
COMPLETED
Abdominal Nerve Blockade in Chronic Heart Failure.
Lead Sponsor:
Duke University
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Patients with chronic heart failure and undergoing right heart catheterization will be enrolled in this study. Subjects will undergo catheterization of the heart to obtain central cardiac pressure and...
Eligibility Criteria
Inclusion
- Diagnosis of heart failure (HF)
- Symptomatic with dyspnea
- On a stable HF drug regimen
Exclusion
- Ongoing treatment with oral anticoagulation other than aspirin
- Immunosuppressive medications for solid organ transplant
- Acute MI (STEMI or Type I NSTEMI) within 7 days
- Systolic blood pressure \< 90 mmHg or \>180 mmHg
- Infiltrative cardiomyopathy or constrictive cardiomyopathy
- Chronic kidney disease stage 5
- Pregnancy
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 27 2019
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT03453151
Start Date
May 1 2018
End Date
December 27 2019
Last Update
July 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke
Durham, North Carolina, United States, 27710